Table 4.
Pharmacokinetic parameters (mean ± SD, n = 3) after oral administration of F5, F7 and FR.
| Formulation | Cmax (μg/mL) | Tmax (h) | AUC0-12h (μg.h/mL) | HVDt50%Cmax (h) | RD (−) | Remaining MTF in tablet (%) |
|---|---|---|---|---|---|---|
| F5 | 1.3 ± 1.0b | 5.3 ± 0.6a | 1.0 ± 1.6b | 10.2 ± 1.7a | 3.2 ± 0.5a | 55.6 ± 4.9a |
| F7 | 2.2 ± 1.0a | 4.3 ± 0.6a | 1.7 ± 1.0a | 9.4 ± 0.9a | 2.9 ± 0.3a | 17.5 ± 2.8b |
| FR | 2.4 ± 1.9a | 2.8 ± 0.4b | 1.5 ± 0.9a | 5.6 ± 0.6b | 1.7 ± 0.2b | – |
a,b Means in the same column with different superscript are different at the 0.05 level of significance.